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Summary. Apolipoprotein H (APO H) has recently been 
identified as a structural component of chylomicrons, very 
low-density lipoproteins (VLDL), low-density lipoproteins 
(LDL), and high-density lipoproteins (HDL). Although the 
precise metabolic function of APO H in lipid metabolism is
not certain, it has been suggested that APO H may be in- 
volved in triglyceride (TG) metabolism. In addition to the 
previously described quantitative polymorphism, we have 
recently detected a common qualitative polymorphism at the 
APO H structural locus. To test the role of APO H genetic 
variation in determining lipoprotein and lipid levels, we have 
estimated the allelic effects of APO H variation on TG, 
VLDL, LDL, HDL, HDL3, and total cholesterol on 356 
Nigerian blacks (189 males, 167 females). While no significant 
effect of phenotype was observed on lipoprotein levels, the 
effect of interaction between phenotype and gender was sig- 
nificant. Therefore, data on males and females were analyzed 
separately using analysis of variance after adjusting for age 
and body mass index. Logarithmic transformation f pertinent 
variables was done to bring the distribution of the variables 
closer to normality. A statistically significant effect of pheno- 
type was observed on triglyceride levels in females only (P < 
0.05). Further analysis of this phenotypic effect revealed that 
it is due to the impact of the APO H*3 allele, which raises tri- 
glycerides by 9.92 mg/dl as compared to the common allele, 
APO H*2. These findings are in accordance with the postu- 
lated role of APO H in triglyceride metabolism. On the basis 
of its sex-specific effect, we propose a hypothesis that may ex- 
plain the combined influence of the quantitative and qualita- 
tive polymorphisms at the APO H locus on triglyceride levels 
in females. 
Introduction 
Apolipoprotein H (APO H) was first isolated by Schultze et 
al. (1961) who proposed the name [~2-glycoprotein I ([3-2- 
GPI). The present name, APO H, was proposed by Nakaya et 
al. (1980), who reported that 13-2-GPI is an activator of the 
enzyme, lipoprotein lipase. APO H is associated with chylo- 
microns, low-density lipoproteins (LDL), very low-density 
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lipoproteins (VLDL) and high-density lipoproteins (HDL: 
Polz and Kostner 1979a, b; Lee et al. 1983). The physiological 
function of APO H in lipid metabolism is not completely 
understood, but it may be involved in triglyceride metabolism 
(Burstein and Legmann 1977; Polz and Kostner 1979a). Addi- 
tional evidence suggests that APO H binds to platelets and 
regulates adenylate cyclase activity (Schousboe 1980). 
The protein is a monomeric glycoprotein with 326 amino 
acid residues and has five attached glycosamine-containing 
oligosaccharide side chains. By comparison to other apolipo- 
proteins, APO H is rich in cysteine and proline; the cysteine 
residues are linked at regular intervals by disulfide bonds. Its 
estimated molecular weight ranges from 43,000 to 50,000 (Lee 
et al. 1983; Lozier et al. 1984). The normal evel of APO H in 
plasma is about 20 mg/100 ml. However, variable levels have 
been observed in individuals, which are controlled genetically 
by two codominantly expressed alleles, designated Bg*N (nor- 
mal), and Bg*D (deficient: Cleve 1968; Koope et al. 1970; 
Propert 1978; Walter et al. 1979). Individuals homozygous for 
the deficient allele have been found immunologically negative 
or nearly so. While heterozygous deficient individuals have a 
concentration of about 10 mg/100 ml. 
Recently, Kamboh et al. (1988) have described a geneti- 
cally determined structural polymorphism in the APO H 
molecule with the occurrence of three common alleles in U.S. 
whites and U.S. blacks. In addition, U.S. blacks were found 
to be unique due to the presence of a fourth allele, APO H*4. 
The role of lipids and apolipoproteins in the atherogenic 
process is well established, and it has been shown that a large 
proportion of the variation in lipid and lipoprotein levels is 
attributable to genetic differences among individuals (Breslow 
1988). However, the role of APO H in determining lipid pro- 
files has not been determined. With the structural polymor- 
phism observed in the APO H molecule, it seems plausible to 
investigate the role of APO H genetic variation in lipid metab- 
olism. We report here an analysis of the effect of this poly- 
morphism on the quantitative l vels of total cholesterol, total 
HDL-C, HDL3-C, LDL-C, and triglycerides in a sample of 
356 unrelated individuals from Nigeria using the measured 
genotype approach (Sing and Davignon 1985; Boerwinkle et 
al. 1986). 
Materials and methods 
Serum samples 
The study population consisted of two groups. The first group 
were first-year medical students, nursing students, and mid- 
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wifery students at the University of Benin, Benin City, 
Nigeria. The second group was a random sample of civil ser- 
vice workers from Benin City, and teachers from the Oroyo 
College Secondary School, Benin City. The two groups pro- 
vided a total sample of 356 unrelated subjects. The mean 
+ SD height and weight of 189 males was 168.0 + 7.5 cm and 
62.87 + 9.44 kg, respectively. The mean + SD height and 
weight of 167 females was 159.5 + 6.10 cm and 58.11 + 9.74 
kg, respectively. They ranged in age from 17 to 54 years with 
a mean + SD age of 30.2 _+ 9.5 years. Detailed descriptions of 
the sample populations are given in Adams-Campbell et al. 
(1988) and Bunker et al. (1989). 
Fasting blood samples were obtained from all the subjects, 
and remained at room temperature for 2 h. Then, the samples 
were centrifuged and the serum pipetted into glass tubes and 
frozen at - 47°C for 2 weeks. The samples were transported to 
Pittsburgh in a styrofoam ice chest with frozen cold packs. The 
lipids were analyzed within 2-4 months after collection in the 
Nutrition Laboratory, University of Pittsburgh, Graduate 
School of Public Health. 
Triglycerides and total serum cholesterol were measured 
manually using an enzymatic method (Bncolo and David 
1973; Allan et al. 1974). Total high-density lipoprotein choles- 
terol (THDL-C) was determined by heparin-manganese chlo- 
ride precipitation methods, whereas subfraction HDL3 cho- 
lesterol concentrations were measured after the precipitation 
of the HDL2-cholesterol subfraction by dextran sulfate (Bucolo 
and David 1973; Gidez et al. 1979; Warwizk and Albers 1978). 
LDL cholesterol was calculated using the Friedewald equation 
(Friedewald et al. 1972). 
Polyacrylamide gel and isoelectric focusing (IEF) 
The polyacrylamide gels of 5% by weight (monomer 4.85%, 
bis 15%) containing 3 M urea were prepared as described pre- 
viously (Kamboh et al. 1988). We mixed 5 ml acrylamide 
(29.1%); 5 ml bis (0.9%); 5.4 g urea; 0.45 ml Pharmalyte, pH 
4-6.5; 0.90 ml Pharmalyte, pH 5-8; and 20 gl riboflavin 
(0.1%) and brought he final volume to 30 ml with deionized 
water. Photopolymerization was achieved by overnight expo- 
sure to fluorescent light and the gel was used the following 
morning. 
Gels were loaded with serum samples absorbed on 5 mm x 
4 mm Whatman 3MM filter paper wicks, close to the cathode. 
Electrode strips were saturated with 1 M H3PO4 for the anode 
and 1 M NaOH for the cathode. Gels were placed into an 
LKB 2217 Ultrophor electrofocusing unit connected to a 
Landa RM6 cooling unit operating at 9°C and an LKB power 
supply at 250 mA maximum current and 10 W constant power. 
The average initial voltage reading was about 540 V and the 
final reading about 1550 V. 
Immunoblotting 
Following IEF, proteins were transferred to either a 0.20 gm 
or 0.45 ~tm pore size nitrocellulose filter by passive diffusion 
(Kamboh and Ferrell 1986) for 20 min. After partial protein 
transfer, the filter was carefully removed from the gel and 
washed in TBS buffer (0.25 M NaC1, 0.03 M Tris-HC1, pH 
8.0) for a few minutes followed by a 15-min incubation with 
5% (w/v) nonfat dry milk dissolved in deionized water to satu- 
rate remaining protein-binding sites. The filter was then ex- 
posed for 30 min to goat anti-human 132-GPI (Atlantic Anti- 
bodies) at 1 gl/1 ml dilution, followed by three 5-min washes 
in TBS. The filter was then probed with a second antibody, 
rabbit anti-goat IgG, conjugated with alkaline phosphatase for 
30 min in TBS at 1~tl/5 ml dilution. The filter was then washed 
with three 5-min washes in TBS and stained histochemically 
using 25 mg 13-naphthyl phosphate, 25 mg Fast Blue BB salt, 
and 60 mg magnesium sulfate in 50 ml buffer (1.8 g NaOH, 
3.7 g boric acid/l). 
Statistical methods 
Allele frequencies were estimated by gene counting. A con- 
tingency chi-square test was used to test for homogeneity 
between the two population samples. For each lipid and 
lipoprotein variable, adjustment were done to remove the 
effects of concomitant variables which were: age, age 2, height, 
height 2, weight, and body mass index (BMI). The adjustment 
was performed in two steps. First, significant concomitant var- 
iables were identified by stepwise regression analysis. Second, 
the multiple regression equation using the significant con- 
comitant variables was estimated for each lipid and lipopro- 
tein variable, and was used to compute the residuals (that is, 
the adjusted values of the variable). 
The adjusted lipid and lipoprotein variables were then ex- 
amined for closeness to the normal distribution by computing 
skewness and kurtosis coefficients. Suitable transformations 
of the adjusted variables were performed to induce normality 
to the extent possible. 
To test whether the mean lipid/lipoprotein profiles are 
equal between genders and among APO H phenotypes, a 
multivariate analysis of variance was performed by consider- 
ing jointly the vectors of mean values of the lipid/lipoprotein 
variables. 
Analyses of variance were used to test differences in mean 
values of adjusted variables between genders and among APO 
H phenotypes. The standard statistical analyses were per- 
formed using SAS, BMDP, and MINITAB program pack- 
ages. Computational formulae used for the average xcess of 
the APO H allele have been given elsewhere (Templeton 
1987). 
Results 
Table 1 shows APO H phenotypes and allele frequencies in a 
sample of 189 males and 167 females from Benin City, Nigeria. 
Observed phenotype frequencies showed no significant devia- 
tion from those expected under Hardy-Weinberg equilibrium. 
Contingency Z 2 analysis revealed no significant differences in 
genotype frequencies between the two sampled groups and 
they were treated as a single homogeneous sample for all anal- 
yses. 
Before estimating the effects of the APO H polymorphism 
on lipid and lipoprotein levels, stepwise regression analyses 
were performed for each lipid variable: total cholesterol (TC), 
total HDL-cholesterol (THDL-C), HDL subfraction choles- 
terol (HDL3-C), low-density lipoprotein cholesterol (LDL- 
C), and triglycerides. The stepwise regression analyses helped 
to identify the significant concomitant variables. The signifi- 
cant (at 5% level) concomitant variables for total cholesterol 
and LDL-C were age and BMI; and for THDL-C, HDL3-C, 
and triglycerides were weight, age, 2 and age, respectively. The 
concomitant variables not entered into the regression equa- 
tion were those that were found to have nonsignificant effects 
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Table 1. Distribution of apolipoprotein H (APO H) phenotypes and allele frequencies inmale and female Nigerian blacks 
Sex Number Phenotypes Allele frequencies 
tested 2-1 2-2 3-2 4-2 APO H*I APO H*2 APO H*3 APO H*4 
Male 189 4 153 24 8 0.011 0.905 0.063 0.021 
Female 167 4 130 26 7 0.012 0.889 0.078 0.021 
Pooled 356 8 283 50 15 0.011 0.897 0.071 0.021 
Table 2. Adjusted mean values a (+ SE) of serum lipid variables in the sample of 356 Nigerian blacks 
Variable (in mg/dl) Apolipoprotein H phenotype 
2-1 2-2 3-2 4-2 Pooled mean 
Total cholesterol 
Total high-density lipoprotein-cholesterol 
High-density lipoprotein 3-cholesterol 
Low-density lipoprotein-cholesterol 
Triglycerides 
167.30 + 11.68 162.67 _+ 1.85 162.21 + 4.88 160.06 + 8.23 162.60 + 1.82 
42.28 + 4.00 46.53 + 0.68 49.59 + 1.68 44.81 + 2.88 46.79 + 0.61 
27.21 + 3.18 30.20 + 0.41 29.77 + 1.08 30.36 + 2.11 30.08 + 0.38 
112.27 + 10.15 102.53 + 1.56 98.24 + 4.32 101.75 + 6.95 102.06 + 1.67 
63.06 + 9.50 68.41 + 1.53 71.76 + 4.42 67.65 + 6.16 68.73 _+ 1.68 
" Adjusted mean value is unadjusted grand mean plus mean of the adjusted residual 
Table 3. Skewness and kurtosis coefficients of the distribution of un- 
transformed and transformed values of adjusted lipid variables 
Variable Untransformed Transformed 
residuals residuals 
Skewness Kurtosis Skewness Kurtosis 
Total cholesterol 0.31 0.18 - 0.63 0.62 
Total high-density 
lipoprotein-cholesterol 0.44 0.48 0.08 0.42 
High-density lipo- 
protein 3-cholesterol 0.26 0.25 0.05 0.18 
Low-density lipo- 
protein-cholesterol 0.19 0.41 -3.20 28.99 
Triglycerides 1.85 5.75 0.65 1.71 
at the 5% level after adjustments were made for the effects of 
the variables already in the equation, The multiple regression 
equations obtained from the stepwise regression analyses 
were then used to adjust he values of the lipid variables. 
The average adjusted lipid and lipoprotein levels among 
individuals with different phenotypes, (i.e., APO H 2-2, 
APO H 2-1, APO H 3-2, APO H 4-2) are presented inTable 
2. Analyses of variance were performed to test equality of 
adjusted mean values of lipid variables between genders and 
among APO H phenotypes. However, before the analyses of 
variance were performed, the skewness and kurtosis coeffi- 
cients of the adjusted lipid variables were computed. The ad- 
justed values were also transformed logarithmically (to base 
10), and the skewness and kurtosis coefficients of the trans- 
formed value were computed to find out whether a logarith- 
mic transformation brought he distribution closer to the nor- 
mal distribution. Some other transformations were also tried, 
but the log (to base 10) transformation was the best. The 
results are given in Table 3, which shows that the logarithmic 
transformation was useful for THDL-C, HDL3-C, and tri- 
glycerides but not for TC and LDL-C. The distributions of 
transformed THDL-C and HDL3-C and untransformed TC 
and LDL-C were fairly close to the normal distribution. The 
analyses of variance were, therefore, performed on the un- 
transformed, adjusted values of TC and LDL-C and on the 
transformed values of THDL-C, HDL3-C, and triglycerides. 
The analyses of variance models included gender and APO H 
phenotypes as the main effects and also the interaction be- 
tween the two. Due to small sample sizes in the APO H 2-1 
and 4-2 phenotype classes, the analyses were performed 
separately either including or excluding both of these classes. 
This was done to avoid vagaries of small sample sizes. 
Before testing equality of mean values for individual lipid 
variables, we tested whether the mean lipid profiles were 
equal between genders and among APO H phenotypes. This 
analysis was performed primarily to determine whether con- 
sideration of individual lipid variables was warranted. The 
Wilks' A values for the multivariate analyses of variance and 
the corresponding approximate F-ratios (Rao 1973) are given 
in the first row of Table 4. While the difference between sexes 
is significant, he differences among APO H phenotypes are 
not significant. Since gender differences in lipid profiles were 
noted, we have also performed univariate analysis of variance 
for each of the lipid variables eparately (Table 4). The sex 
effect was significant on TC and LDL-C, but the effect of 
APO H phenotypes was not significant on any of the lipid 
parameters. The interaction effect between sex and pheno- 
type was only significant for HDL3-C. Because of this signif- 
icant interaction, separate adjusted mean lipid values were 
estimated for males and females (Table 5). Since the inter- 
action term was significant only for HDL3-C, we performed 
one-way analyses of variance separately for each sex, includ- 
ing and excluding APO H 2-1 and APO H 4-2 phenotypes. 
The effect of phenotype inmales was not significant. When in 
females APO H 2-1 and 4-2 phenotypes were included, the 
effect of phenotype was significant (F = 3.02, P < 0.05) on 
HDL3-C. However, if these two phenotypes were excluded, 
the effect of phenotype was significant (F -- 4.43, P < 0.05) 
for triglycerides in females. We estimated the average xcesses 
of the APO H alleles on HDL3-C (including APO H 2-1 and 
4-2 phenotypes). The average xcesses of the APO H*I  and 
APO H*2 alleles were -6.25 mg/dl and -0.08 mg/dl, re- 
spectively, while the average xcesses of the APO H*3 and 
APO H*4 alleles were 0.20 mg/dl and 6.16 mg/dl, respective- 
ly. We estimated also the average xcesses of APO H alleles 
on triglycerides (excluding APO H 2-1 and 4-2 phenotypes). 
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Table 4. Two-way analysis of variance for testing significance and the effect of sex, apolipoprotein H phenotype, and interaction between sex and 
phenotype. * Significant at 5% level 
Variable F-ratio for the effect of 
Sex Phenotype Sex x phenotype 
Including Excluding Including Excluding Including Excluding 
2-1 & 4-2 2-1 & 4-2 2-1 & 4-2 2-1 & 4-2 2-1 & 4-2 2-1 & 4-2 
phenotypes phenotypes phenotypes phenotypes phenotypes phenotypes 
All (multivariate) a 
Total cholesterol 
Total high-density lipoprotein-cholesterol 
High-density lipoprotein 3-cholesterol 
Low-density lipoprotein-cholesterol 
Triglycerides 
3.71"(5,344) b 3.63* (5,325) 1.10(15,950) 1.92 (5,325) 1.24(15,950) 
8.82"(1,348) 8.11"(1,329) 0.10 (3,348) 0.01 (1,329) 0.O9 (3,348) 
2.12 (1,348) 1.11 (1,329) 1.61 (3,348) 2.98 (1,329) 1.47 (3,348) 
0.02 (1,348) 0.24 (1,329) 0.55 (3,348) 0.18 (1,329) 2.74*(3,348) 
8.80* (1,348) 8.59* (1,329) 0.65 (3,348) 0.93 (1,329) 0.07 (3,348) 
3.07 (1,348) 2.62 (1,329) 0.39 (3,348) 0.58 (1,329) 1.89 (3,348) 
1.73 (5,325) 
0.24 (1,329) 
0.31 (1,329) 
0.53 (1,329) 
0.01 (1,329) 
2.76"(1,329) 
a F-ratio for the multivariate t st are approximate (Rao 1973) 
b Figures in parentheses indicate degrees of freedom 
Table 5. Adjusted mean values a(+ SE) of serum lipid variables in the sample of Nigerian black males (n = 189) and females (n = 167) 
Variable (in mg/dl) Sex Apolipoprotein H phenotype 
2-1 2-2 3-2 4-2 Pooled mean 
Total cholesterol M 
F 
Total high-density lipoprotein-cholesterol M
F 
High-density lipoprotein 3-cholesterol M 
F 
Low-density lipoprotein-cholesterol M 
F 
Triglycerides M 
F 
162.87 _+ 22.24 160.80 _+ 2.48 157.16 _+ 6.27 
168.43 + 12.94 164.80 + 2.65 167.19 _+ 7.25 
43.23 + 5.87 45.58 + 0.97 47.35 + 2.15 
41.53 + 6.56 47.22 + 0.93 51.46 + 2.37 
30.31 + 6.47 30.87 + 0.60 29.68 + 1.71 
23.72 + 0.67 29.40 + 0.55 29.76 + 1.36 
107.66 + 16.17 99.26 _+ 2.38 94.86 _+ 5.92 
114.80 + 13.82 106.20 + 2.39 102.22 + 6.18 
60.30 + 17.06 78.33 + 2.66 74.67 + 4.88 
60.60 + 8.23 56.91 +__ 1.68 68.75 __+ 7.22 
159.77 + 
162.43 + 
40.17 + 
52.15 + 
26.54 + 
35.34 +_ 
103.02 _+ 
99.15 + 
82.76 -- 
51.58 + 
12.81 
9.72 
3.92 
2.37 
2.34 
2.70 
10.92 
8.90 
10.28 
2.95 
160.34 
165.16 
45.77 
47.95 
30.53 
29.57 
99.04 
105.49 
77.67 
58.62 
+ 2.60 
_+ 2.53 
+ 0.87 
+ 0.85 
+ 0.56 
+ 0.50 
_+ 2.37 
_+ 2.31 
+ 2.53 
+ 1.87 
a Adjusted mean value is unadjusted grand mean plus mean of the adjusted residual 
The average xcess of the APO H*2 allele was -0 .90  mg/dl, 
while that of the APO H*3 allele was 9.92 mg/dl in females. 
Discussion 
Genetically determined structural variation in various apo- 
lipoproteins, which are structural components of l ipoprotein 
particles, plays an important role in determining interindi- 
vidual lipid variation and susceptibility to cardiovascular dis- 
eases (Breslow 1988; Humphries 1988). The precise function 
of APO H in lipid metabolism is unknown. However,  as a 
constituent of various l ipoprotein particles, and possessing 
genetic variation, the APO H gene products have a potential 
role in determining quantitative levels of l ipoprotein lipids 
(Burstein and Legmann 1977; Polz and Kostner 1979a). To 
evaluate its role in lipid metabolism, we have screened a large 
number of Nigerian blacks for the APO H genetic polymor- 
phism. Furthermore, the effect of genetic variation has been 
investigated on triglycerides, total cholesterol, total HDL-C,  
LDL-C,  and HDL3-C.  The present study did not demonstrate 
any significant effect of APO H phenotype on quantitative 
levels of lipid and lipoproteins in 356 Nigerians tested. How- 
ever, the interaction effect between phenotype and sex was 
found to be significant for HDL3-C (Table 4). Therefore, 
separate analyses were performed for males and females. A 
statistically significant effect of phenotype was revealed on 
HDL3-C in females only. This significant effect was contrib- 
uted largely by the small numbers present in the APO H 2-1 
and 4-2 phenotype classes. When these two minor phenotype 
classes were excluded from the analysis, the phenotypic effect 
was non-significant for HDL3-C.  It is unclear from this analy- 
sis whether the effect of APO H polymorphism on HDL3-C in 
females was real or due to vagaries of small sample sizes. 
Further studies, with larger sample sizes are needed to con- 
firm these findings. In any case, the effects of APO H*2 and 
APO H*3 alleles on HDL3-C were negligible, while those of 
APO H*I and APO H*4 were large and in opposite directions. 
While APO H*I lowered the level of HDL3-C,  APO H*4 had 
an elevating effect. The exclusion of the 2-1 and 4-2 pheno- 
types showed a dramatic change and yielded a significant 
effect (at the 5% level) of phenotype on triglycerides in 
females. This observation prompted us to estimate the allelic 
effects. The average adjusted values of triglycerides in the 
remaining APO H 2-2 and 3-2 phenotypes were 56.91 mg/dl 
and 68.75 mg/dl, respectively (Table 5), giving rise to a signif- 
icant difference of 11.84 mg/dl at the 5% level. In comparison 
with the effect of the APO H*2 allele on triglycerides (which 
was negligible), the APO H*3 allele had a large elevating 
effect on triglyceride levels in females. 
Our present observation on the allelic effect of APO H on 
triglycerides is in accordance with its postulated function in 
triglyceride metabolism. Burstein and Legmann (1977) first 
reported a correlation between APO H deficiency and ele- 
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vated levels of VLDL. Subsequently Nakaya et al. (1980) 
demonstrated that in vitro APO H increases the enzymatic 
activity of the lipoprotein lipase (LPL) enzyme in the presence 
of APO C-II. These studies are confirmed by in vivo studies 
where APO H was found to be involved in the clearance of 
triglycerides from plasma (Wurm et al. 1982). Our finding that 
the APO H locus influences triglyceride levels only in females 
needs to be confirmed in other population samples. However, 
from the existing information available on APO H, we may 
suggest he following hypothesis of its sex-specific effect on 
triglycerides in the Nigerians. In addition to the recently 
described qualitative polymorphism (Kamboh et al. 1988), 
APO H is known to demonstrate quantitative polymorphism 
(Cleve 1968; Propert 1978; Walter et al. 1979). Two alleles, 
Bg*N (normal) and Bg*D (deficiency), have been document- 
ed. The frequency of the deficiency allele in Caucasians and 
blacks differ significantly with respective values of about 5% 
and 20%. The average concentration of APO H is significant- 
ly higher in Caucasians than in blacks (Walter et al. 1979). 
While there are no data on sex differences among blacks, the 
Caucasian females have relatively low levels of APO H com- 
pared to males (Cleve 1968; Propert 1978). To be consistent 
with these observations one may speculate that black females 
have the lowest values of APO H. Assuming further that the 
APO H*3 allele is associated with the deficiency trait (quan- 
titative polymorphism), this would cause further decline in 
APO H values among females carrying this alle product. Such 
a drastic reduction in APO H may make this protein a poor 
activator of the LPL enzyme and lead to the accumulation of
triglycerides or VLDL in the plasma. The same mechanism 
may occur in males, but since they have already comparative- 
ly higher values of APO H than females, the effect of the 
APO H*3 allele may be moderate. It is likely that different 
hormonal profiles of females may be another contributing 
determinant of this sex-specific effect. The advantage of the 
proposed hypothesis is that it is easily testable. Studies are 
underway in our laboratory to evaluate the relationship be- 
tween the qualitative and quantitative genetic polymorphisms 
and their role in lipid metabolism. 
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